Alnylam Pharmaceuticals
ALNY
#442
Rank
โ‚ฌ45.08 B
Marketcap
341,26ย โ‚ฌ
Share price
0.98%
Change (1 day)
48.46%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company